U.S. panel to review heart inflammation cases after Pfizer, Moderna vaccines
June 23 (Reuters) - Advisers to the U.S. Centers for Disease Control and Prevention (CDC) are set to meet on Wednesday to assess the possibility of a link between rare cases of heart inflammation and the mRNA COVID-19 vaccines from Pfizer (PFE.N) and partner BioNTech and from Moderna (MRNA.O).
The CDC has been investigating cases of heart inflammation mainly in young men for several months. The Israeli health ministry earlier this month said it saw a possible link between such cases and Pfizer's COVID-19 vaccine.